美国重症监护室收治的合并基础肾脏病COVID-19患者的特征与结局
该回顾性队列研究纳入美国68家医院ICU收治的4,264例COVID-19危重患者,其中143例为维持性透析的肾衰竭患者,521例为非透析依赖性CKD患者,3,600例无基础CKD。校正后透析患者28天院内死亡风险显著增高(aHR 1.41,95%CI 1.09-1.81),非透析依赖性CKD患者风险居中(aHR 1.25,95%CI 1.08-1.44)。
要点
- 透析患者28天院内死亡风险较无CKD患者显著增高(aHR 1.41)。
- 非透析依赖性CKD患者死亡风险居中(aHR 1.25),仍需加强关注。
核心结论
- 合并基础肾脏病的COVID-19危重患者死亡率高,透析患者风险最高,非透析依赖性CKD患者风险居中。
研究设计与样本
- 回顾性队列研究,纳入美国68家医院ICU收治的4,264例COVID-19危重患者。
- 其中维持性透析的肾衰竭患者143例,非透析依赖性CKD患者521例,无基础CKD患者3,600例。
主要发现
- 透析患者从症状出现至ICU入院的中位时间短于其他组(透析4天[IQR 2-9],非透析CKD 7天[IQR 3-10],无CKD 7天[IQR 4-10])。
- 透析患者中25%报告精神状态改变,高于非透析CKD的20%(标准化差异0.12)和无CKD的12%(标准化差异0.36)。
- 校正后透析患者28天院内死亡风险高于无CKD患者(aHR 1.41,95%CI 1.09-1.81),非透析依赖性CKD患者风险居中(aHR 1.25,95%CI 1.08-1.44)。
临床怎么用
- 对合并基础肾脏病的COVID-19危重患者应加强监护和早期干预,透析患者尤其需要关注。
局限性
- 存在潜在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Underlying kidney disease is an emerging risk factor for more severe coronavirus disease 2019 (COVID-19) illness. We examined the clinical courses of critically ill COVID-19 patients with and without pre-existing chronic kidney disease (CKD) and investigated the association between the degree of underlying kidney disease and in-hospital outcomes. STUDY DESIGN: Retrospective cohort study. SETTINGS & PARTICIPANTS: 4,264 critically ill patients with COVID-19 (143 patients with pre-existing kidney failure receiving maintenance dialysis; 521 patients with pre-existing non-dialysis-dependent CKD; and 3,600 patients without pre-existing CKD) admitted to intensive care units (ICUs) at 68 hospitals across the United States. PREDICTOR(S): Presence (vs absence) of pre-existing kidney disease. OUTCOME(S): In-hospital mortality (primary); respiratory failure, shock, ventricular arrhythmia/cardiac arrest, thromboembolic events, major bleeds, and acute liver injury (secondary). ANALYTICAL APPROACH: We used standardized differences to compare patient characteristics (values>0.10 indicate a meaningful difference between groups) and multivariable-adjusted Fine and Gray survival models to examine outcome associations. RESULTS: Dialysis patients had a shorter time from symptom onset to ICU admission compared to other groups (median of 4 [IQR, 2-9] days for maintenance dialysis patients; 7 [IQR, 3-10] days for non-dialysis-dependent CKD patients; and 7 [IQR, 4-10] days for patients without pre-existing CKD). More dialysis patients (25%) reported altered mental status than those with non-dialysis-dependent CKD (20%; standardized difference=0.12) and those without pre-existing CKD (12%; standardized difference=0.36). Half of dialysis and non-dialysis-dependent CKD patients died within 28 days of ICU admission versus 35% of patients without pre-existing CKD. Compared to patients without pre-existing CKD, dialysis patients had higher risk for 28-day in-hospital death (adjusted HR, 1.41 [95% CI, 1.09-1.81]), while patients with non-dialysis-dependent CKD had an intermediate risk (adjusted HR, 1.25 [95% CI, 1.08-1.44]). LIMITATIONS: Potential residual confounding. CONCLUSIONS: Findings highlight the high mortality of individuals with underlying kidney disease and severe COVID-19, underscoring the importance of identifying safe and effective COVID-19 therapies in this vulnerable population.
引用
- Flythe JE, Assimon MM, Tugman MJ, et al. Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2020. PMID: 32961244. doi:10.1053/j.ajkd.2020.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。